Grant: Discovery Grants Program - Individual
Université de Montréal
$67,000.00
Next generation immunopeptidomics
EF 2024-25
Résumé
All vertebrate nucleated cells display at their surface antigen peptides that signal their metabolic status to T-cells of the immune system. These short peptides are presented by major histocompatibility complex (MHC) molecules, and play important roles in adaptive immunity. T-cells scrutinize the repertoire of MHC-associated peptides (MAPs, also know as the immunopeptidome) to determine antigens that belong to the cell (self) from those that do not (non-self or foreign). While MAPs are typically associated with canonical proteins, recent reports indicated that up to 5% of the immunopeptidome can derive from allegedly non-coding RNAs (e.g. cryptic antigens). MAPs cannot be predicted from genomic or proteomic datasets, and their identification relies on immunopurification of the MHC complex, and peptide sequencing using high sensitivity mass spectrometry (MS). However, these analyses are limited by the large amounts of cells required and the lack of appropriate databases to correlate MS spectra to sequences encoded by all genomic regions. To address these limitations, this proposal will develop new analytical approaches that will enhance MAP identification to uncover the "dark immunopeptidome". We will apply these tools and methods to understand the molecular mechanisms associated with the biogenesis of antigens and how their presentation at the cell surface is affected by different cellular and environmental cues. To fulfill these goals we propose three interrelated objectives. First, we will enhance the sensitivity of immunopeptidomic analyses by improving the recovery and scalability of immunoaffinity purification methods to profile thousands of MAPs from less than a million cells. We will also apply new MS acquisition and ion mobility methods to improve the detection of low abundance MAPs from cell extracts. Second, we will use polysome profiling to generate customized databases that include sample-specific canonical and non-canonical proteins to constrain search space expansion and enable the identification of MAPs from all relevant genomic regions. Third, we will use CRISPR/Cas9 gene editing and quantitative MS to interrogate changes in the immunopeptidome upon deletion of ubiquitin-like modifier (ULM) enzymes (i.e. E3 SUMO and ISG15 ligases) regulating MHC expression and gene transcription. The availability of cells expressing different ULM enzymes will provide a convenient tool to correlate changes in the abundance of E3 ligase substrates with those from the immunopeptidome. We anticipate that these developments will not only address unmet needs in immunopeptidomics, but will also further our understanding of the function and importance of ULM in human health and cell immunity.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-04375
Name nom
Thibault, Pierre
Department département
Chemistry
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
67000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next generation immunopeptidomics
Keywords
mass spectrometry; peptide sequencing; affinity chromatography; separation sciences; ion mobility; ubiquitin-like modifiers; immunopeptidomics; proteomics; peptide antigens; protein sumoylation
Application summary
All vertebrate nucleated cells display at their surface antigen peptides that signal their metabolic status to T-cells of the immune system. These short peptides are presented by major histocompatibility complex (MHC) molecules, and play important roles in adaptive immunity. T-cells scrutinize the repertoire of MHC-associated peptides (MAPs, also know as the immunopeptidome) to determine antigens that belong to the cell (self) from those that do not (non-self or foreign). While MAPs are typically associated with canonical proteins, recent reports indicated that up to 5% of the immunopeptidome can derive from allegedly non-coding RNAs (e.g. cryptic antigens). MAPs cannot be predicted from genomic or proteomic datasets, and their identification relies on immunopurification of the MHC complex, and peptide sequencing using high sensitivity mass spectrometry (MS). However, these analyses are limited by the large amounts of cells required and the lack of appropriate databases to correlate MS spectra to sequences encoded by all genomic regions. To address these limitations, this proposal will develop new analytical approaches that will enhance MAP identification to uncover the "dark immunopeptidome". We will apply these tools and methods to understand the molecular mechanisms associated with the biogenesis of antigens and how their presentation at the cell surface is affected by different cellular and environmental cues. To fulfill these goals we propose three interrelated objectives. First, we will enhance the sensitivity of immunopeptidomic analyses by improving the recovery and scalability of immunoaffinity purification methods to profile thousands of MAPs from less than a million cells. We will also apply new MS acquisition and ion mobility methods to improve the detection of low abundance MAPs from cell extracts. Second, we will use polysome profiling to generate customized databases that include sample-specific canonical and non-canonical proteins to constrain search space expansion and enable the identification of MAPs from all relevant genomic regions. Third, we will use CRISPR/Cas9 gene editing and quantitative MS to interrogate changes in the immunopeptidome upon deletion of ubiquitin-like modifier (ULM) enzymes (i.e. E3 SUMO and ISG15 ligases) regulating MHC expression and gene transcription. The availability of cells expressing different ULM enzymes will provide a convenient tool to correlate changes in the abundance of E3 ligase substrates with those from the immunopeptidome. We anticipate that these developments will not only address unmet needs in immunopeptidomics, but will also further our understanding of the function and importance of ULM in human health and cell immunity.